India to Venezuela: Everolimus Export Trade Route

The India to Venezuela Everolimus corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $460.3K USD. The route is dominated by MEDWISE OVERSEAS PRIVATE LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's everolimus manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $38.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with everolimus's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 15.9%, placing it at rank #8 among India's top everolimus export destinations globally.

On the import side, key buyers of Indian everolimus in Venezuela include TO, MIFAR FARMACEUTICA CA, BIOMEDICA SUPPLY C.A.AV.SEXTA TRANS and 5 others. TO is the single largest importer with 3 shipments valued at $219.6K USD.

India's everolimus exports to Venezuela are driven primarily by a handful of large-scale manufacturers. MEDWISE OVERSEAS PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Venezuela benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDWISE OVERSEAS PRIVATE LIMITED, S D PHARMACEUTICALS, ZYREX HEALTHCARE PRIVATE LIMITED — together account for 87% of total trade value on this route. The average shipment value of $38.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as everolimus tablet 10mg batch no otherdetail as per inv packing list and pharmaceutical product for human consumption-afilimus 10 mg-everolimus tablet 10mg (1s)nos, suggesting that buyers in Venezuela tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO is the largest importer with 3 shipments worth $219.6K USD — representing 48% of all everolimus imports from India on this route. A total of 8 buyers are active on this corridor.